Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Boor

Showing results (31-40 of 356) with videos related to

Pageof 36
Sort By:
Der Pathologe|October 5, 2021
[Update on thoracic pathology 2021-report of the working group thoracic pathology of the German Society of Pathology]Sabina Berezowska, Peter Boor, Danny Jonigk, et al.
Kidney & Blood Pressure Research|January 31, 2007
Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute?Katarína Sebeková, Zoltán Wagner, Nicole Schupp, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2007
Treatment targets in renal fibrosisPeter Boor, Katarína Sebeková, Tammo Ostendorf, et al.
Biotechnology Advances|April 30, 2013
In vivo phage display--a discovery tool in molecular biomedicineJanka Bábíčková, Ľubomíra Tóthová, Peter Boor, et al.
Pathologie (Heidelberg, Germany)|September 16, 2022
[Update on collaborative autopsy-based research in German pathology, neuropathology, and forensic medicine]Saskia von Stillfried, Benita Freeborn, Svenja Windeck, et al.
Current Opinion in Cell Biology|January 21, 2015
Keratins in health and diseaseDiana M Toivola, Peter Boor, Catharina Alam, et al.
Current Opinion in Pharmacology|November 1, 2019
Pathology and natural history of organ fibrosisJoaquim Majo, Barbara Mara Klinkhammer, Peter Boor, et al.
Advances in Chronic Kidney Disease|March 13, 2017
Treatment of Renal Fibrosis-Turning Challenges into OpportunitiesBarbara M Klinkhammer, Roel Goldschmeding, Jürgen Floege, et al.
Contributions to Nephrology|May 15, 2007
The role of PDGF-D in mesangioproliferative glomerulonephritisJürgen Floege, Claudia van Roeyen, Peter Boor, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 4, 2015
Salivary markers of kidney function - Potentials and limitationsPeter Celec, Ľubomíra Tóthová, Katarína Šebeková, et al.
Pageof 36

Showing results (31-40 of 356) with videos related to

Sort By:
Pageof 36
Der Pathologe|October 5, 2021
[Update on thoracic pathology 2021-report of the working group thoracic pathology of the German Society of Pathology]Sabina Berezowska, Peter Boor, Danny Jonigk, et al.
Kidney & Blood Pressure Research|January 31, 2007
Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute?Katarína Sebeková, Zoltán Wagner, Nicole Schupp, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2007
Treatment targets in renal fibrosisPeter Boor, Katarína Sebeková, Tammo Ostendorf, et al.
Biotechnology Advances|April 30, 2013
In vivo phage display--a discovery tool in molecular biomedicineJanka Bábíčková, Ľubomíra Tóthová, Peter Boor, et al.
Pathologie (Heidelberg, Germany)|September 16, 2022
[Update on collaborative autopsy-based research in German pathology, neuropathology, and forensic medicine]Saskia von Stillfried, Benita Freeborn, Svenja Windeck, et al.
Current Opinion in Cell Biology|January 21, 2015
Keratins in health and diseaseDiana M Toivola, Peter Boor, Catharina Alam, et al.
Current Opinion in Pharmacology|November 1, 2019
Pathology and natural history of organ fibrosisJoaquim Majo, Barbara Mara Klinkhammer, Peter Boor, et al.
Advances in Chronic Kidney Disease|March 13, 2017
Treatment of Renal Fibrosis-Turning Challenges into OpportunitiesBarbara M Klinkhammer, Roel Goldschmeding, Jürgen Floege, et al.
Contributions to Nephrology|May 15, 2007
The role of PDGF-D in mesangioproliferative glomerulonephritisJürgen Floege, Claudia van Roeyen, Peter Boor, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 4, 2015
Salivary markers of kidney function - Potentials and limitationsPeter Celec, Ľubomíra Tóthová, Katarína Šebeková, et al.
Pageof 36